Recent Study – DermaBug Patch

Recent Study
In 2009, The Bugpatch was tested by a researcher in a heavily mosquito-infested region of Africa by the Siouxland Tanzania Education and Medical Ministry.

Be Invisible To Insects

The Derma Bug Patch is a 100% Organic and DEET-free bug deterrent that offers full day head-to-toe protection from insects with a single application!

Fortified With Vitamin B1
Each Patch Lasts Up To 36 Hours
Mosquitos, No-See-Ums, Black Flies, Yellow Flies, Ticks

Results

One member, a registered nurse, received 8 mosquito bites the first night.

The recommended second patch was added and she received no more bites.

Each adult member put on two patches due to the extreme mosquito conditions and rotated one patch each 24-36 hrs.

Each participant responded well resulting in complete mosquito protection.

Location & Participants
- Location: Tanzania, Africa
- Participants: 14 adult volunteers
Study
For two weeks, each volunteer put one patch on a different part of their skin for 24 hours.
Side Effects
No participants acknowledge any side effects wearing the patches. A few participants revealed some extra alertness and energy.
Conclusion
The field testing revealed that in extreme mosquito conditions an adult must wear two patches and rotating one every 24-48 hrs. The application of patches prior to exposure is 2 to 4 hrs. for best results.

What others say about us

“I have used them when fishing, camping, riding horses and other sports. DEET does not repel horse flies but Bug Patch does! Thank you for making something so safe that works so well.”

WikiTravel

“I have always hated putting DEET and other chemicals on my kids because of the dangers associated with them but Bug Patch is totally safe.”

Media Wiki

“I would strongly recommend The Bug Patch from a personal as well as professional evaluation by my Mission Team in Panama. It provided outstanding protection.”

Max Mobilcom

“The patch is easy to apply and lasts from 36-48 hours. I did not experience any irritation at the site of application or any side effects.”

Doom Inc

Disclosures & Forward Looking Statements* These statements have not been evaluated by the Food and Drug Administration.* This product is not intended to diagnose, treat, cure or prevent any disease.

This communication contains statements of a forward-looking nature about NutraFuels, Inc. fka NutraLife BioSciences, Inc., and its wholly owned subsidiary, NutraDerma Technologies, Inc. (the “Company”). These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. You can identify these forward-looking statements by words or phrases such as “may,” “will,” “except,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “is/are likely to,” “future” or other similar expressions. The Company has based these forward-looking statements largely on the Company’s current expectations and projections about future events and financial trends that the Company believes may affect Company’s financial condition, results of operations, business strategy, and financial needs. There is no assurance that Company’s current expectations and projections concerning its ability to commercialize the patented insect dermal patch are accurate. All forward-looking statements in this packet of information are based on information available to the Company on the date hereof. These statements involve known and unknown risks, uncertainties and other factors that may cause the Company’s actual results to differ materially from those implied by the forward-looking statements. More detailed information about these risk factors are set forth in the Company’s filings with the Securities and Exchange Commission, including, but not limited to, those risks and uncertainties listed in the section entitled “Risk Factors,” in the Company’s Annual Report on Form 10-K with the Securities and Exchange Commission on April 17, 2018. The Company operates in a rapidly evolving environment. New risk factors emerge from time to time, and it is impossible for the Company’s management to predict all risk factors, nor can the Company assess the impact of all factors on Company’s business or the extent to which any factor, or combination of factors, may cause actual results to differ from those contained in any forward-looking statement. The Company does not undertake any obligation to update or revise the forward-looking statements except as required under applicable law.